Carolyn LaWell, Author at ORTHOWORLD

China’s Directives Set to Reshape Orthopaedic Market

The Chinese government has prioritized medical device development, as well as local and international investments by domestic device companies. Whether you're a leader in the Chinese market or thinking of entering, its important to understand the trends and government initiatives shaping the country's orthopaedic industry.

Jan 20, 2017

Revisiting Predictions: Orthobiologics, Insurance and ASCs

Executive Insights Industry Voices

How device manufacturers, surgeons and insurance companies are shaping the future of sustainable medicine.

Dec 15, 2016

Recap: NASS Week 2016

Company Updates Competitive Landscape

At NASS 2016, enabling technologies of all kinds generated the most pre- and post-event buzz. Implants made with 3D printing technologies were highlighted, too, as were companies’ responses to changes in healthcare delivery.

Nov 18, 2016

NASS Preview: Growing Spine – International Markets, MIS and Product Portfolios

Competitive Landscape Market Drivers

Eric Muehlbauer, Executive Director and CEO of NASS, sits in an interesting position in the spine industry in that he serves multiple stakeholders, from surgeons to device companies, to suppliers and service providers, around the globe. In speaking with him about NASS' priorities, as well as where the greatest opportunities lie for surgeons and device companies, these three topics arose.

Aug 19, 2016

NASS Preview: NASS Stresses a Proactive Approach to Drive Reimbursement in Spine

ORTHOFLASH Spine

Surgeons and device companies face a similar challenge with reimbursement: it continues to be one of the greater barriers for technology adoption today due to payor pushback. With no foreseeable easement expected to come from private or public payors, surgeons and device companies must embrace a proactive approach.

Aug 18, 2016

NASS Preview: NASS Survey Finds Spine Professionals Independent and Influencing Decisions

Industry Voices Surgeon Interviews

In 2015, NASS conducted a survey taken by nearly 650 Members in the U.S. to support a clearer understanding of its Members practice settings.

Aug 16, 2016

Wright’s Dedication to Extremities Strategies Brings Questions of What’s Next

Company Updates Competitive Landscape

Wright Medical's divestiture of its large joint portfolio to Corin Orthopaedics officially turns Wright into the extremities company that it set out to become years ago, and leads to the question: What's next in their M&A strategy?

Jul 22, 2016

Developing New Orthopaedic Business Models: 2020 and Beyond

Actionable Advice Industry Voices

To thrive in the healthcare environment of tomorrow, orthopaedic device companies will need to operate within a greater portion of the supply chain, assisting upstream and downstream customers in finding operational value. This will require companies to forge stronger relationships, focus on internal efficiencies and launch services, not just devices.

Jul 22, 2016

Arthroscopy/Soft Tissue Companies Address Meniscus, Rotator Cuff Repair

Executive Insights Industry Voices

The arthroscopy/soft tissue segment reached sales of $4.5 billion in 2015, a four percent increase over 2014, according to ORTHOWORLD estimates. Growth in the market is buoyed by several factors: strength of the main players, smaller players expanding their portfolios to complement other product lines, industry focus and surgeon adoption of minimally invasive techniques and surgeons' push to drive new technologies and techniques in ligament and tendon care and repair.

Apr 22, 2016

Bundled Payments: AAOS Conversations Center on CJR and Beyond

Executive Insights Industry Voices

The advent of the Centers for Medicare & Medicaid's Comprehensive Care for Joint Replacement (CJR) program fueled AAOS Annual Meeting conversations regarding the best response by hospitals, surgeons and device companies to bundled payment reimbursement models, including those that extend beyond joint reconstruction.

Mar 18, 2016

Get the ORTHOWORLD Newsletter!

Contact Us